Taken together, we demonstrated the induction of autoreactive CD49d+CD154+ lymphocytes in MS patients in PBMCs exposed to myelin peptides and confirmed the role of CD154-CD40 interaction in this process. The gene discussed is CD40LG; the disease is myeloid sarcoma.